Retraction to: Gene Therapy
10.1038/s41434-019-0109-0
The Editor-in-Chief has retracted this article [1] due to concerns regarding the figures and the underlying data. The authors informed the journal that they have not been able to reproduce the results presented in the article. Further investigation found significant text overlap with an article by different authors that was simultaneously under consideration at the same time at another journal [2]. Additionally, there appear to be overlapping figures between the two articles:
The bottom left two panels of Fig. 4f of [1] appear to be identical to the bottom left and bottom right panels of Fig. 2b of [2].
The TAC panel in Fig. 4g of [1] TAC image appears to be a reflection (y axis) of the TAC+control in Fig. 4g of [1].
The data reported in this article are therefore unreliable. ChangSheng Ma agrees with this retraction. The other authors have not responded to correspondence regarding this retraction.
Footnotes
The original article can be found online at 10.1038/s41434-019-0109-0.
References
- 1.Wang W, Liu N, Xin L. et al. Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6. Gene Ther. 2019. 10.1038/s41434-019-0109-0. [DOI] [PMC free article] [PubMed] [Retracted]
- 2.Xu L, Wang H, Jiang F, Sun H, Zhang D. LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway. Aging. 2020;12:3126–39. doi: 10.18632/aging.102668. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]